| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 25 | 2023 | 284 | 1.930 |
Why?
|
| Tandem Mass Spectrometry | 14 | 2022 | 147 | 1.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 7 | 2014 | 93 | 0.870 |
Why?
|
| Mass Spectrometry | 19 | 2019 | 301 | 0.820 |
Why?
|
| Depression, Postpartum | 4 | 2020 | 129 | 0.790 |
Why?
|
| Proteome | 12 | 2022 | 149 | 0.740 |
Why?
|
| Serotonin Syndrome | 1 | 2020 | 10 | 0.690 |
Why?
|
| Francisella tularensis | 7 | 2011 | 21 | 0.650 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2018 | 75 | 0.630 |
Why?
|
| Peptides | 14 | 2025 | 574 | 0.630 |
Why?
|
| Prenatal Care | 1 | 2020 | 170 | 0.590 |
Why?
|
| Peptide Mapping | 5 | 2014 | 29 | 0.590 |
Why?
|
| Lipid A | 6 | 2012 | 66 | 0.580 |
Why?
|
| Extracellular Vesicles | 3 | 2023 | 45 | 0.520 |
Why?
|
| Membrane Proteins | 7 | 2023 | 894 | 0.510 |
Why?
|
| Steroids | 1 | 2016 | 55 | 0.500 |
Why?
|
| Conservation of Natural Resources | 2 | 2025 | 39 | 0.450 |
Why?
|
| Bacterial Proteins | 11 | 2021 | 766 | 0.450 |
Why?
|
| Pregnanolone | 4 | 2020 | 14 | 0.440 |
Why?
|
| Chromatography, Liquid | 10 | 2022 | 131 | 0.430 |
Why?
|
| Mycobacterium tuberculosis | 4 | 2022 | 406 | 0.430 |
Why?
|
| Animals | 47 | 2025 | 20631 | 0.420 |
Why?
|
| Interferon Type I | 3 | 2023 | 187 | 0.410 |
Why?
|
| Depression | 1 | 2020 | 891 | 0.410 |
Why?
|
| Protein Interaction Mapping | 4 | 2021 | 68 | 0.410 |
Why?
|
| Mental Disorders | 1 | 2020 | 791 | 0.400 |
Why?
|
| Mice | 33 | 2023 | 10827 | 0.400 |
Why?
|
| Lipid Metabolism | 4 | 2016 | 220 | 0.390 |
Why?
|
| Cathepsin B | 2 | 2015 | 13 | 0.380 |
Why?
|
| Polyglutamic Acid | 3 | 2006 | 11 | 0.370 |
Why?
|
| Humans | 63 | 2025 | 63292 | 0.370 |
Why?
|
| Cysteine | 3 | 2021 | 107 | 0.370 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 721 | 0.360 |
Why?
|
| Brain | 6 | 2023 | 1555 | 0.350 |
Why?
|
| Paclitaxel | 3 | 2006 | 99 | 0.350 |
Why?
|
| Models, Molecular | 7 | 2021 | 1148 | 0.350 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 2 | 2008 | 44 | 0.340 |
Why?
|
| Macrophages | 7 | 2020 | 1038 | 0.330 |
Why?
|
| Endoplasmic Reticulum | 2 | 2023 | 173 | 0.330 |
Why?
|
| Huntington Disease | 4 | 2017 | 154 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 17 | 2021 | 3391 | 0.320 |
Why?
|
| Nucleotidyltransferases | 3 | 2023 | 61 | 0.300 |
Why?
|
| Ubiquitination | 2 | 2021 | 111 | 0.300 |
Why?
|
| Ions | 6 | 2009 | 56 | 0.300 |
Why?
|
| 20-alpha-Dihydroprogesterone | 2 | 2020 | 7 | 0.300 |
Why?
|
| Desoxycorticosterone | 2 | 2020 | 7 | 0.300 |
Why?
|
| Models, Chemical | 2 | 2007 | 136 | 0.290 |
Why?
|
| Cerebral Cortex | 3 | 2018 | 260 | 0.280 |
Why?
|
| Immunity, Innate | 4 | 2021 | 796 | 0.280 |
Why?
|
| Progesterone | 2 | 2020 | 163 | 0.280 |
Why?
|
| Pregnenolone | 2 | 2020 | 4 | 0.280 |
Why?
|
| Astrocytes | 3 | 2022 | 119 | 0.270 |
Why?
|
| Antigen Presentation | 3 | 2025 | 237 | 0.270 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2019 | 53 | 0.260 |
Why?
|
| Data Mining | 2 | 2021 | 38 | 0.260 |
Why?
|
| Athletic Injuries | 2 | 2017 | 83 | 0.250 |
Why?
|
| Genetic Therapy | 3 | 2022 | 789 | 0.240 |
Why?
|
| Movement | 2 | 2017 | 156 | 0.240 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2018 | 65 | 0.240 |
Why?
|
| Cell Line | 10 | 2021 | 2037 | 0.240 |
Why?
|
| Aquatic Organisms | 1 | 2025 | 8 | 0.240 |
Why?
|
| Animal Distribution | 1 | 2025 | 4 | 0.240 |
Why?
|
| Databases, Protein | 4 | 2014 | 48 | 0.230 |
Why?
|
| Telemetry | 1 | 2025 | 19 | 0.230 |
Why?
|
| Biodiversity | 1 | 2025 | 38 | 0.230 |
Why?
|
| Animal Migration | 1 | 2025 | 22 | 0.230 |
Why?
|
| Amino Acid Sequence | 12 | 2021 | 1592 | 0.230 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2022 | 263 | 0.230 |
Why?
|
| Cytokines | 3 | 2025 | 934 | 0.230 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1254 | 0.220 |
Why?
|
| Ecosystem | 1 | 2025 | 53 | 0.220 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2017 | 82 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 663 | 0.210 |
Why?
|
| Triglycerides | 2 | 2016 | 244 | 0.210 |
Why?
|
| Glycoproteins | 2 | 2019 | 187 | 0.210 |
Why?
|
| Neurons | 6 | 2023 | 923 | 0.210 |
Why?
|
| Coronavirus OC43, Human | 1 | 2023 | 3 | 0.210 |
Why?
|
| Islets of Langerhans | 1 | 2025 | 279 | 0.210 |
Why?
|
| Cells, Cultured | 10 | 2019 | 2152 | 0.210 |
Why?
|
| Female | 21 | 2022 | 32787 | 0.210 |
Why?
|
| DNA Helicases | 2 | 2015 | 190 | 0.210 |
Why?
|
| Yeasts | 2 | 2014 | 49 | 0.200 |
Why?
|
| Oxidative Stress | 3 | 2015 | 297 | 0.200 |
Why?
|
| Dependovirus | 3 | 2022 | 709 | 0.200 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2022 | 28 | 0.200 |
Why?
|
| Amyloid Neuropathies, Familial | 1 | 2022 | 16 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2017 | 228 | 0.190 |
Why?
|
| Protein Structure, Secondary | 2 | 2021 | 260 | 0.190 |
Why?
|
| Pregnancy | 3 | 2020 | 2330 | 0.190 |
Why?
|
| Gramicidin | 2 | 1999 | 6 | 0.190 |
Why?
|
| Cytochrome c Group | 2 | 1999 | 25 | 0.190 |
Why?
|
| Golgi Apparatus | 2 | 2019 | 64 | 0.190 |
Why?
|
| Sarcoglycans | 1 | 2022 | 4 | 0.190 |
Why?
|
| Myoglobin | 2 | 1999 | 27 | 0.190 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 147 | 0.190 |
Why?
|
| Rhabdomyosarcoma | 1 | 2022 | 16 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2022 | 52 | 0.190 |
Why?
|
| Amyloidosis | 1 | 2022 | 65 | 0.190 |
Why?
|
| Carbon | 1 | 2022 | 51 | 0.190 |
Why?
|
| Drug Interactions | 1 | 2022 | 127 | 0.190 |
Why?
|
| Gene-Environment Interaction | 1 | 2022 | 49 | 0.180 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2019 | 503 | 0.180 |
Why?
|
| Cytochromes b5 | 3 | 2012 | 3 | 0.180 |
Why?
|
| Hepatitis C, Chronic | 1 | 2022 | 88 | 0.180 |
Why?
|
| Codon, Nonsense | 1 | 2022 | 58 | 0.180 |
Why?
|
| Macrophage Activation | 3 | 2020 | 119 | 0.180 |
Why?
|
| Blood Proteins | 2 | 2013 | 76 | 0.180 |
Why?
|
| Indole-3-Glycerol-Phosphate Synthase | 1 | 2021 | 4 | 0.180 |
Why?
|
| Antitubercular Agents | 1 | 2022 | 82 | 0.180 |
Why?
|
| Cell Wall | 1 | 2022 | 118 | 0.180 |
Why?
|
| Molecular Sequence Data | 10 | 2016 | 1990 | 0.180 |
Why?
|
| Mitochondrial Diseases | 2 | 2012 | 22 | 0.180 |
Why?
|
| Proteins | 5 | 2011 | 751 | 0.180 |
Why?
|
| Huntingtin Protein | 3 | 2017 | 143 | 0.180 |
Why?
|
| Citrullination | 1 | 2021 | 36 | 0.180 |
Why?
|
| Cross-Linking Reagents | 4 | 2012 | 116 | 0.170 |
Why?
|
| Gyrus Cinguli | 2 | 2018 | 57 | 0.170 |
Why?
|
| Myeloid Cells | 1 | 2021 | 94 | 0.170 |
Why?
|
| Dimethyl Fumarate | 1 | 2020 | 8 | 0.170 |
Why?
|
| Familial Mediterranean Fever | 1 | 2020 | 9 | 0.170 |
Why?
|
| Software | 3 | 2010 | 389 | 0.170 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2016 | 344 | 0.170 |
Why?
|
| Thiazoles | 1 | 2020 | 47 | 0.170 |
Why?
|
| Phosphate-Binding Proteins | 1 | 2020 | 19 | 0.170 |
Why?
|
| Computational Biology | 4 | 2011 | 356 | 0.170 |
Why?
|
| Protein Domains | 1 | 2021 | 147 | 0.170 |
Why?
|
| Dysbiosis | 1 | 2021 | 65 | 0.170 |
Why?
|
| Acetylation | 4 | 2015 | 122 | 0.170 |
Why?
|
| Factor Xa Inhibitors | 1 | 2020 | 35 | 0.170 |
Why?
|
| Colitis | 1 | 2021 | 77 | 0.170 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2020 | 59 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2020 | 620 | 0.170 |
Why?
|
| Pyroptosis | 1 | 2020 | 32 | 0.160 |
Why?
|
| Parturition | 1 | 2020 | 55 | 0.160 |
Why?
|
| Gene Expression Regulation | 7 | 2018 | 1617 | 0.160 |
Why?
|
| Liver | 6 | 2018 | 851 | 0.160 |
Why?
|
| Risk Factors | 3 | 2020 | 5338 | 0.160 |
Why?
|
| Pyridines | 1 | 2020 | 111 | 0.160 |
Why?
|
| Ion Transport | 1 | 1999 | 21 | 0.160 |
Why?
|
| Male | 16 | 2021 | 29814 | 0.160 |
Why?
|
| Adult | 9 | 2020 | 16782 | 0.160 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 780 | 0.160 |
Why?
|
| Roseolovirus Infections | 1 | 2019 | 10 | 0.160 |
Why?
|
| Phosphorylation | 6 | 2022 | 937 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2023 | 641 | 0.150 |
Why?
|
| Disease Models, Animal | 10 | 2017 | 2180 | 0.150 |
Why?
|
| Signal Transduction | 7 | 2023 | 3033 | 0.150 |
Why?
|
| Herpesvirus 6, Human | 1 | 2019 | 17 | 0.150 |
Why?
|
| Hexosyltransferases | 1 | 2019 | 40 | 0.150 |
Why?
|
| Shiga Toxins | 1 | 2018 | 2 | 0.150 |
Why?
|
| Ricin | 1 | 2018 | 3 | 0.150 |
Why?
|
| Tularemia | 2 | 2009 | 15 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2017 | 1514 | 0.150 |
Why?
|
| Spectrometry, Mass, Secondary Ion | 1 | 1998 | 7 | 0.150 |
Why?
|
| Lysine Acetyltransferases | 1 | 2018 | 3 | 0.150 |
Why?
|
| Creatine | 1 | 2018 | 24 | 0.150 |
Why?
|
| HLA-D Antigens | 1 | 2018 | 19 | 0.150 |
Why?
|
| Algorithms | 4 | 2021 | 1001 | 0.150 |
Why?
|
| Ubiquitins | 1 | 1998 | 41 | 0.150 |
Why?
|
| Cell Differentiation | 5 | 2018 | 1348 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2015 | 559 | 0.150 |
Why?
|
| Muscle, Skeletal | 4 | 2022 | 738 | 0.150 |
Why?
|
| Connectome | 1 | 2018 | 33 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 337 | 0.140 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 25 | 0.140 |
Why?
|
| Mutation | 10 | 2022 | 2607 | 0.140 |
Why?
|
| RNA | 2 | 2022 | 423 | 0.140 |
Why?
|
| Exosomes | 1 | 2018 | 48 | 0.140 |
Why?
|
| Rett Syndrome | 1 | 2017 | 8 | 0.140 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 182 | 0.140 |
Why?
|
| Motor Neurons | 1 | 2019 | 212 | 0.140 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2015 | 441 | 0.140 |
Why?
|
| Depressive Disorder | 1 | 2020 | 284 | 0.140 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 15 | 0.140 |
Why?
|
| Menthol | 1 | 2017 | 6 | 0.140 |
Why?
|
| DNA, Protozoan | 1 | 2017 | 50 | 0.140 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 218 | 0.140 |
Why?
|
| Hypoxia | 1 | 2018 | 115 | 0.140 |
Why?
|
| Yersinia pestis | 3 | 2012 | 33 | 0.140 |
Why?
|
| Genetic Variation | 2 | 2011 | 383 | 0.140 |
Why?
|
| Case-Control Studies | 2 | 2021 | 1121 | 0.140 |
Why?
|
| Anxiety | 1 | 2020 | 424 | 0.130 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2017 | 32 | 0.130 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2018 | 87 | 0.130 |
Why?
|
| Lysosomal Storage Diseases | 1 | 2016 | 14 | 0.130 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 319 | 0.130 |
Why?
|
| Universities | 1 | 2017 | 158 | 0.130 |
Why?
|
| Synaptosomes | 2 | 2015 | 16 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 1 | 2016 | 26 | 0.130 |
Why?
|
| Locomotion | 1 | 2017 | 116 | 0.130 |
Why?
|
| Tuberculosis | 2 | 2017 | 295 | 0.130 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 225 | 0.130 |
Why?
|
| Nicotine | 1 | 2017 | 117 | 0.130 |
Why?
|
| Peripartum Period | 1 | 2016 | 21 | 0.130 |
Why?
|
| Athletes | 1 | 2017 | 109 | 0.130 |
Why?
|
| Receptors, GABA-A | 1 | 2016 | 25 | 0.130 |
Why?
|
| Nitric Oxide | 1 | 2017 | 174 | 0.120 |
Why?
|
| Glycosylation | 3 | 2023 | 138 | 0.120 |
Why?
|
| Lipopolysaccharides | 3 | 2020 | 625 | 0.120 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 6 | 0.120 |
Why?
|
| Membrane Microdomains | 1 | 2016 | 49 | 0.120 |
Why?
|
| Mycobacterium | 1 | 2016 | 36 | 0.120 |
Why?
|
| HLA-DR1 Antigen | 1 | 2016 | 27 | 0.120 |
Why?
|
| AIDS Dementia Complex | 1 | 2015 | 11 | 0.120 |
Why?
|
| DNA Repair | 2 | 2015 | 236 | 0.120 |
Why?
|
| Students | 1 | 2017 | 217 | 0.120 |
Why?
|
| Peptide Hydrolases | 2 | 2022 | 77 | 0.120 |
Why?
|
| SNARE Proteins | 1 | 2015 | 26 | 0.120 |
Why?
|
| Protein Kinase C beta | 1 | 2015 | 6 | 0.120 |
Why?
|
| Gene Expression | 4 | 2014 | 839 | 0.120 |
Why?
|
| Host-Pathogen Interactions | 2 | 2015 | 262 | 0.120 |
Why?
|
| Plasmodium falciparum | 1 | 2017 | 246 | 0.120 |
Why?
|
| Cholesterol | 1 | 2016 | 260 | 0.120 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2015 | 19 | 0.120 |
Why?
|
| Glycerophospholipids | 1 | 2015 | 4 | 0.120 |
Why?
|
| Phosphatidic Acids | 1 | 2015 | 8 | 0.120 |
Why?
|
| beta-Galactosidase | 1 | 2015 | 77 | 0.120 |
Why?
|
| Calcineurin | 1 | 2015 | 47 | 0.120 |
Why?
|
| Lysophospholipids | 1 | 2015 | 27 | 0.120 |
Why?
|
| Muscle Development | 1 | 2015 | 53 | 0.110 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2014 | 3 | 0.110 |
Why?
|
| Dystroglycans | 1 | 2014 | 4 | 0.110 |
Why?
|
| Vesicular Transport Proteins | 1 | 2015 | 113 | 0.110 |
Why?
|
| Cells | 1 | 2014 | 32 | 0.110 |
Why?
|
| Meibomian Glands | 1 | 2014 | 3 | 0.110 |
Why?
|
| Heart Failure | 1 | 2022 | 913 | 0.110 |
Why?
|
| Inflammation | 2 | 2021 | 1146 | 0.110 |
Why?
|
| Benzoquinones | 1 | 2014 | 14 | 0.110 |
Why?
|
| Reproducibility of Results | 7 | 2013 | 1649 | 0.110 |
Why?
|
| Serum | 1 | 2014 | 27 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 26 | 0.110 |
Why?
|
| Neutrophils | 1 | 2017 | 376 | 0.110 |
Why?
|
| Dystrophin | 1 | 2014 | 31 | 0.110 |
Why?
|
| Genetic Vectors | 3 | 2022 | 872 | 0.110 |
Why?
|
| Lactams, Macrocyclic | 1 | 2014 | 25 | 0.110 |
Why?
|
| Taxoids | 2 | 2005 | 26 | 0.110 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2016 | 199 | 0.110 |
Why?
|
| DNA Damage | 2 | 2015 | 280 | 0.110 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 142 | 0.110 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2014 | 33 | 0.110 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2012 | 15 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2015 | 158 | 0.110 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 696 | 0.110 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 424 | 0.110 |
Why?
|
| Fungal Proteins | 1 | 2014 | 147 | 0.110 |
Why?
|
| DNA | 2 | 2023 | 832 | 0.110 |
Why?
|
| Lipogenesis | 1 | 2014 | 68 | 0.100 |
Why?
|
| Epitopes | 1 | 2014 | 289 | 0.100 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2015 | 232 | 0.100 |
Why?
|
| Central Nervous System | 1 | 2015 | 197 | 0.100 |
Why?
|
| Laboratories | 1 | 2013 | 27 | 0.100 |
Why?
|
| Fatty Acids | 1 | 2014 | 200 | 0.100 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2012 | 12 | 0.100 |
Why?
|
| Prospective Studies | 1 | 2020 | 3285 | 0.100 |
Why?
|
| Temperature | 3 | 2012 | 307 | 0.100 |
Why?
|
| Methionine | 1 | 2013 | 55 | 0.100 |
Why?
|
| Dendritic Cells | 1 | 2016 | 524 | 0.100 |
Why?
|
| Serine O-Acetyltransferase | 1 | 2012 | 3 | 0.100 |
Why?
|
| Peptide Fragments | 3 | 2009 | 410 | 0.100 |
Why?
|
| Mice, Knockout | 4 | 2017 | 2107 | 0.100 |
Why?
|
| Francisella | 1 | 2012 | 3 | 0.100 |
Why?
|
| Glutamic Acid | 1 | 2013 | 100 | 0.100 |
Why?
|
| Acyltransferases | 1 | 2012 | 31 | 0.100 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2012 | 39 | 0.100 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2012 | 14 | 0.100 |
Why?
|
| Nerve Net | 1 | 2013 | 97 | 0.090 |
Why?
|
| Lysine | 1 | 2012 | 83 | 0.090 |
Why?
|
| Fanconi Anemia Complementation Group Proteins | 1 | 2012 | 34 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 129 | 0.090 |
Why?
|
| Muscular Diseases | 1 | 2012 | 50 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2014 | 389 | 0.090 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1184 | 0.090 |
Why?
|
| HeLa Cells | 3 | 2019 | 535 | 0.090 |
Why?
|
| Mixed Function Oxygenases | 1 | 2011 | 19 | 0.090 |
Why?
|
| Genome | 2 | 2018 | 276 | 0.090 |
Why?
|
| Reference Standards | 4 | 2013 | 73 | 0.090 |
Why?
|
| Halobacterium salinarum | 1 | 2011 | 1 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 29 | 0.090 |
Why?
|
| Computer Simulation | 2 | 2007 | 477 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 158 | 0.090 |
Why?
|
| Tretinoin | 1 | 2011 | 50 | 0.090 |
Why?
|
| tau Proteins | 2 | 2022 | 202 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 226 | 0.090 |
Why?
|
| Child | 1 | 2020 | 4522 | 0.090 |
Why?
|
| Serine-Type D-Ala-D-Ala Carboxypeptidase | 1 | 2010 | 1 | 0.090 |
Why?
|
| Purkinje Cells | 1 | 2010 | 6 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 985 | 0.080 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2023 | 181 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2012 | 211 | 0.080 |
Why?
|
| Microfluidics | 1 | 2010 | 25 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2015 | 705 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1073 | 0.080 |
Why?
|
| Sensitivity and Specificity | 4 | 2013 | 1146 | 0.080 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 82 | 0.080 |
Why?
|
| HIV-1 | 1 | 2015 | 721 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 72 | 0.080 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2009 | 93 | 0.080 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 151 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2012 | 84 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2009 | 45 | 0.080 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 84 | 0.080 |
Why?
|
| Protein Binding | 4 | 2016 | 1602 | 0.080 |
Why?
|
| Lipoproteins | 1 | 2009 | 83 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2019 | 1465 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2021 | 384 | 0.080 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 382 | 0.080 |
Why?
|
| Horses | 2 | 1999 | 52 | 0.080 |
Why?
|
| Acetylcholine | 1 | 2008 | 44 | 0.080 |
Why?
|
| ADP Ribose Transferases | 1 | 2008 | 62 | 0.080 |
Why?
|
| Immunodominant Epitopes | 2 | 2019 | 56 | 0.080 |
Why?
|
| Diphosphates | 1 | 2008 | 11 | 0.080 |
Why?
|
| Cattle | 3 | 2011 | 308 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2009 | 45 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2008 | 35 | 0.070 |
Why?
|
| Stromal Cells | 1 | 2009 | 67 | 0.070 |
Why?
|
| Kinetics | 3 | 2021 | 760 | 0.070 |
Why?
|
| Gram-Negative Bacteria | 1 | 2008 | 57 | 0.070 |
Why?
|
| Risk Assessment | 1 | 2015 | 2071 | 0.070 |
Why?
|
| Prostate | 1 | 2009 | 90 | 0.070 |
Why?
|
| HIV Infections | 1 | 2015 | 967 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2008 | 132 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 130 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2018 | 2164 | 0.070 |
Why?
|
| Neurogenesis | 1 | 2008 | 64 | 0.070 |
Why?
|
| Gases | 1 | 2008 | 21 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2008 | 70 | 0.070 |
Why?
|
| Genes, Bacterial | 1 | 2008 | 118 | 0.070 |
Why?
|
| Energy Metabolism | 1 | 2010 | 379 | 0.070 |
Why?
|
| Erythrocytes | 2 | 2017 | 149 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 879 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 1276 | 0.070 |
Why?
|
| Nucleotides, Cyclic | 2 | 2017 | 16 | 0.070 |
Why?
|
| Protease Inhibitors | 2 | 2022 | 102 | 0.070 |
Why?
|
| Oncorhynchus kisutch | 1 | 2006 | 1 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2014 | 247 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2006 | 41 | 0.070 |
Why?
|
| NF-kappa B | 2 | 2023 | 469 | 0.070 |
Why?
|
| Oxidation-Reduction | 3 | 2014 | 325 | 0.060 |
Why?
|
| Environment | 1 | 2007 | 122 | 0.060 |
Why?
|
| Protein Folding | 2 | 2021 | 267 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 1 | 2006 | 40 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 131 | 0.060 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2006 | 223 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 129 | 0.060 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 922 | 0.060 |
Why?
|
| Hepatocytes | 2 | 2018 | 217 | 0.060 |
Why?
|
| Histones | 3 | 2015 | 483 | 0.060 |
Why?
|
| Extinction, Biological | 1 | 2025 | 8 | 0.060 |
Why?
|
| Phenotype | 3 | 2017 | 1200 | 0.060 |
Why?
|
| Endangered Species | 1 | 2025 | 7 | 0.060 |
Why?
|
| Pacific Islands | 1 | 2025 | 4 | 0.060 |
Why?
|
| Binding Sites | 3 | 2015 | 903 | 0.060 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 203 | 0.060 |
Why?
|
| Rats | 3 | 2017 | 1977 | 0.060 |
Why?
|
| Lysosomes | 2 | 2016 | 167 | 0.060 |
Why?
|
| Blotting, Western | 3 | 2013 | 608 | 0.060 |
Why?
|
| Autoantigens | 1 | 2025 | 138 | 0.060 |
Why?
|
| Microbial Viability | 2 | 2016 | 55 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2017 | 1539 | 0.050 |
Why?
|
| Biomarkers | 3 | 2022 | 1396 | 0.050 |
Why?
|
| Recombinant Proteins | 3 | 2014 | 701 | 0.050 |
Why?
|
| Sequence Alignment | 3 | 2010 | 300 | 0.050 |
Why?
|
| Research Design | 1 | 2007 | 573 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 2 | 2015 | 43 | 0.050 |
Why?
|
| Insulin-Secreting Cells | 1 | 2025 | 190 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 19 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2023 | 13 | 0.050 |
Why?
|
| Spinal Cord | 2 | 2015 | 204 | 0.050 |
Why?
|
| Ovarian Neoplasms | 1 | 2005 | 148 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2023 | 17 | 0.050 |
Why?
|
| Esterases | 1 | 2023 | 13 | 0.050 |
Why?
|
| Young Adult | 3 | 2018 | 4683 | 0.050 |
Why?
|
| Monocytes | 2 | 2021 | 353 | 0.050 |
Why?
|
| ROC Curve | 2 | 2017 | 281 | 0.050 |
Why?
|
| Corpus Striatum | 2 | 2015 | 97 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2005 | 166 | 0.050 |
Why?
|
| Receptors, Peptide | 1 | 2023 | 34 | 0.050 |
Why?
|
| Seasons | 1 | 2023 | 134 | 0.050 |
Why?
|
| Cathepsin L | 1 | 2022 | 22 | 0.050 |
Why?
|
| Prealbumin | 1 | 2022 | 19 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 2015 | 51 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2021 | 778 | 0.050 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2022 | 5 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2023 | 113 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2017 | 319 | 0.050 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2003 | 88 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2022 | 79 | 0.050 |
Why?
|
| Heterozygote | 1 | 2022 | 169 | 0.050 |
Why?
|
| Amyloid | 1 | 2022 | 69 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2022 | 23 | 0.050 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cerebellum | 2 | 2015 | 94 | 0.050 |
Why?
|
| Nonsense Mediated mRNA Decay | 1 | 2022 | 27 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2022 | 38 | 0.050 |
Why?
|
| Integrin beta1 | 1 | 2022 | 32 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2022 | 93 | 0.050 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 373 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 671 | 0.050 |
Why?
|
| Transfection | 2 | 2016 | 692 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2022 | 121 | 0.050 |
Why?
|
| Biocatalysis | 1 | 2021 | 48 | 0.050 |
Why?
|
| Gene Silencing | 2 | 2018 | 399 | 0.050 |
Why?
|
| Citrulline | 1 | 2021 | 44 | 0.040 |
Why?
|
| Escherichia coli | 3 | 2014 | 700 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2022 | 276 | 0.040 |
Why?
|
| RNA Interference | 2 | 2015 | 618 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2021 | 86 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 489 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2022 | 89 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 129 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 201 | 0.040 |
Why?
|
| Styrenes | 1 | 2020 | 3 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 124 | 0.040 |
Why?
|
| Drosophila melanogaster | 2 | 2017 | 498 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2021 | 196 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 363 | 0.040 |
Why?
|
| Citric Acid Cycle | 1 | 2020 | 28 | 0.040 |
Why?
|
| Albumins | 1 | 2020 | 35 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2025 | 1007 | 0.040 |
Why?
|
| Adsorption | 1 | 2020 | 83 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 147 | 0.040 |
Why?
|
| Amino Acids | 1 | 2021 | 146 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 621 | 0.040 |
Why?
|
| Intestines | 1 | 2021 | 167 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2020 | 302 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2022 | 322 | 0.040 |
Why?
|
| Ion-Selective Electrodes | 1 | 1999 | 2 | 0.040 |
Why?
|
| Species Specificity | 2 | 2011 | 334 | 0.040 |
Why?
|
| Enkephalin, Leucine | 1 | 1999 | 7 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 297 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 1999 | 14 | 0.040 |
Why?
|
| Coat Protein Complex I | 1 | 2019 | 5 | 0.040 |
Why?
|
| Arsenites | 1 | 2019 | 7 | 0.040 |
Why?
|
| Transduction, Genetic | 2 | 2012 | 237 | 0.040 |
Why?
|
| HLA-DR3 Antigen | 1 | 2019 | 7 | 0.040 |
Why?
|
| Virulence | 2 | 2012 | 193 | 0.040 |
Why?
|
| Cytoplasmic Granules | 1 | 2019 | 52 | 0.040 |
Why?
|
| Epitope Mapping | 1 | 2019 | 50 | 0.040 |
Why?
|
| Caspases | 1 | 2020 | 174 | 0.040 |
Why?
|
| Trihexosylceramides | 1 | 2018 | 1 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2018 | 9 | 0.040 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2018 | 12 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2018 | 23 | 0.040 |
Why?
|
| Molecular Weight | 2 | 2009 | 187 | 0.040 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 33 | 0.040 |
Why?
|
| Umbilical Cord | 1 | 2018 | 9 | 0.040 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 27 | 0.040 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2019 | 78 | 0.040 |
Why?
|
| Glycolipids | 1 | 2018 | 44 | 0.040 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 148 | 0.040 |
Why?
|
| Sequence Analysis, Protein | 2 | 2010 | 34 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2019 | 135 | 0.040 |
Why?
|
| Multifunctional Enzymes | 1 | 2018 | 17 | 0.040 |
Why?
|
| Bacterial Toxins | 1 | 2018 | 61 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 670 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2009 | 108 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 134 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2018 | 82 | 0.030 |
Why?
|
| Endonucleases | 1 | 2018 | 83 | 0.030 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2017 | 8 | 0.030 |
Why?
|
| Cognitive Dysfunction | 1 | 2022 | 332 | 0.030 |
Why?
|
| Endosomes | 1 | 2018 | 178 | 0.030 |
Why?
|
| Interferon Regulatory Factor-3 | 1 | 2017 | 97 | 0.030 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2017 | 14 | 0.030 |
Why?
|
| Polyubiquitin | 1 | 2017 | 9 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 182 | 0.030 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2017 | 24 | 0.030 |
Why?
|
| Protein Transport | 1 | 2018 | 401 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2017 | 39 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2018 | 289 | 0.030 |
Why?
|
| Middle Aged | 3 | 2022 | 17549 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 54 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2009 | 881 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2019 | 566 | 0.030 |
Why?
|
| Age of Onset | 1 | 2017 | 174 | 0.030 |
Why?
|
| Adolescent | 2 | 2017 | 6238 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 274 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2018 | 359 | 0.030 |
Why?
|
| Interleukin-1 | 1 | 2017 | 156 | 0.030 |
Why?
|
| Inflammasomes | 1 | 2020 | 334 | 0.030 |
Why?
|
| Bacterial Secretion Systems | 1 | 2016 | 10 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 760 | 0.030 |
Why?
|
| Trypsin | 2 | 2006 | 39 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 174 | 0.030 |
Why?
|
| Gelsolin | 1 | 2016 | 5 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2016 | 12 | 0.030 |
Why?
|
| Thymosin | 1 | 2016 | 8 | 0.030 |
Why?
|
| Lymph | 1 | 2016 | 10 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2011 | 771 | 0.030 |
Why?
|
| Calgranulin B | 1 | 2015 | 6 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 619 | 0.030 |
Why?
|
| Complement C3 | 1 | 2016 | 59 | 0.030 |
Why?
|
| Chromatography, Gel | 1 | 2015 | 65 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 447 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2015 | 60 | 0.030 |
Why?
|
| Genotype | 1 | 2017 | 664 | 0.030 |
Why?
|
| Iron | 1 | 2016 | 147 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 1329 | 0.030 |
Why?
|
| Gangliosides | 1 | 2015 | 18 | 0.030 |
Why?
|
| Brain Stem | 1 | 2015 | 28 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2015 | 48 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 483 | 0.030 |
Why?
|
| Oxidoreductases | 1 | 2015 | 64 | 0.030 |
Why?
|
| Malaria, Falciparum | 1 | 2017 | 220 | 0.030 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2014 | 4 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 27 | 0.030 |
Why?
|
| Synaptic Vesicles | 1 | 2015 | 25 | 0.030 |
Why?
|
| Genomics | 1 | 2018 | 370 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2016 | 265 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 358 | 0.030 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2015 | 28 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2014 | 15 | 0.030 |
Why?
|
| Hybridomas | 1 | 2014 | 63 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2015 | 58 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 78 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2014 | 40 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 139 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 201 | 0.030 |
Why?
|
| Serine | 1 | 2014 | 91 | 0.030 |
Why?
|
| PPAR alpha | 1 | 2014 | 34 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 224 | 0.030 |
Why?
|
| Transcriptome | 1 | 2017 | 388 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 136 | 0.030 |
Why?
|
| Exercise Test | 1 | 2015 | 252 | 0.030 |
Why?
|
| Eye Proteins | 1 | 2014 | 74 | 0.030 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2015 | 162 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2014 | 143 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1375 | 0.030 |
Why?
|
| Myoblasts | 1 | 2014 | 63 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 153 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 676 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 126 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 207 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 126 | 0.030 |
Why?
|
| Ethyldimethylaminopropyl Carbodiimide | 1 | 2012 | 4 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 11 | 0.020 |
Why?
|
| Amygdala | 1 | 2013 | 83 | 0.020 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2012 | 16 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1084 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2012 | 28 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 784 | 0.020 |
Why?
|
| Plague | 1 | 2012 | 23 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 39 | 0.020 |
Why?
|
| Body Temperature | 1 | 2012 | 45 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2012 | 9 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2012 | 23 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 860 | 0.020 |
Why?
|
| Carnitine | 1 | 2012 | 19 | 0.020 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 59 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 158 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2013 | 122 | 0.020 |
Why?
|
| Testosterone | 1 | 2012 | 121 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 58 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 26 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 3759 | 0.020 |
Why?
|
| Chromosome Segregation | 1 | 2011 | 40 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme Inhibitors | 1 | 2011 | 4 | 0.020 |
Why?
|
| Retinoic Acid 4-Hydroxylase | 1 | 2011 | 4 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 293 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2011 | 8 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 222 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 242 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2012 | 122 | 0.020 |
Why?
|
| Hippocampus | 1 | 2013 | 270 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2013 | 195 | 0.020 |
Why?
|
| Phylogeny | 1 | 2012 | 376 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 2571 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 99 | 0.020 |
Why?
|
| Acoustics | 1 | 2010 | 11 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2010 | 36 | 0.020 |
Why?
|
| Retinal Degeneration | 1 | 2010 | 27 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 335 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2009 | 2 | 0.020 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2009 | 11 | 0.020 |
Why?
|
| Hyperoxia | 1 | 2009 | 17 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2014 | 863 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 135 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 416 | 0.020 |
Why?
|
| Cell Extracts | 1 | 2009 | 25 | 0.020 |
Why?
|
| Retina | 1 | 2010 | 124 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2010 | 290 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1006 | 0.020 |
Why?
|
| Ribosomes | 1 | 2011 | 163 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 94 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2008 | 4 | 0.020 |
Why?
|
| Carbachol | 1 | 2008 | 17 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2009 | 197 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 364 | 0.020 |
Why?
|
| Diglycerides | 1 | 2008 | 24 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2009 | 121 | 0.020 |
Why?
|
| Mesoderm | 1 | 2009 | 85 | 0.020 |
Why?
|
| Disulfides | 1 | 2008 | 64 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 78 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 195 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2008 | 32 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2008 | 42 | 0.020 |
Why?
|
| Chemical Fractionation | 1 | 2008 | 13 | 0.020 |
Why?
|
| Oxygen Isotopes | 1 | 2008 | 10 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2008 | 84 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2008 | 199 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2007 | 96 | 0.020 |
Why?
|
| Macrophages, Alveolar | 1 | 2008 | 64 | 0.020 |
Why?
|
| Chromosomes, Fungal | 1 | 2007 | 35 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 373 | 0.020 |
Why?
|
| Freezing | 1 | 2007 | 19 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2007 | 129 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 866 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2008 | 96 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2007 | 25 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2008 | 204 | 0.020 |
Why?
|
| Pseudogenes | 1 | 2007 | 12 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 238 | 0.020 |
Why?
|
| Ethacrynic Acid | 1 | 2006 | 1 | 0.020 |
Why?
|
| Dinitrochlorobenzene | 1 | 2006 | 3 | 0.020 |
Why?
|
| Atrazine | 1 | 2006 | 2 | 0.020 |
Why?
|
| Methyl Parathion | 1 | 2006 | 3 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2008 | 144 | 0.020 |
Why?
|
| Drosophila | 1 | 2010 | 435 | 0.020 |
Why?
|
| Bilirubin | 1 | 2006 | 18 | 0.020 |
Why?
|
| Herbicides | 1 | 2006 | 19 | 0.020 |
Why?
|
| Bias | 1 | 2007 | 112 | 0.020 |
Why?
|
| Mitochondria | 1 | 2010 | 371 | 0.020 |
Why?
|
| Stem Cells | 1 | 2008 | 258 | 0.020 |
Why?
|
| Fourier Analysis | 1 | 2006 | 32 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2007 | 67 | 0.020 |
Why?
|
| Insecticides | 1 | 2006 | 44 | 0.020 |
Why?
|
| Ammonia | 1 | 2006 | 14 | 0.020 |
Why?
|
| Automation | 1 | 2006 | 54 | 0.020 |
Why?
|
| Carbon Monoxide | 1 | 2006 | 62 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2006 | 86 | 0.020 |
Why?
|
| DNA Transposable Elements | 1 | 2007 | 140 | 0.020 |
Why?
|
| Cytosol | 1 | 2006 | 179 | 0.020 |
Why?
|
| DNA Primers | 1 | 2006 | 291 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2006 | 58 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2007 | 389 | 0.010 |
Why?
|
| Half-Life | 1 | 2005 | 80 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2005 | 142 | 0.010 |
Why?
|
| Area Under Curve | 1 | 2005 | 147 | 0.010 |
Why?
|
| United States | 1 | 2017 | 7826 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 322 | 0.010 |
Why?
|
| Water | 1 | 2006 | 309 | 0.010 |
Why?
|
| Melanoma, Experimental | 1 | 2003 | 44 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 734 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 453 | 0.010 |
Why?
|
| Aged | 1 | 2014 | 14390 | 0.010 |
Why?
|